MILIND JAVLE to Matrix Metalloproteinase 2
This is a "connection" page, showing publications MILIND JAVLE has written about Matrix Metalloproteinase 2.
Connection Strength
0.017
-
A phase I pharmacokinetic and pharmacodynamic study of s-3304, a novel matrix metalloproteinase inhibitor, in patients with advanced and refractory solid tumors. Clin Cancer Res. 2007 Apr 01; 13(7):2091-9.
Score: 0.017